What is Avilys?
Avilys Sleep & EEG operates as a comprehensive medical practice dedicated to the diagnosis and treatment of a spectrum of sleep disorders. The company distinguishes itself through high-quality patient care and an efficient referral system designed to expedite physician-to-patient treatment pathways. Equipped with state-of-the-art, accredited facilities that prioritize patient comfort and adhere to stringent health protocols, Avilys serves both individuals experiencing sleep disturbances and healthcare providers seeking reliable sleep study services.
How much funding has Avilys raised?
Avilys has raised a total of $257K across 1 funding round:
Debt
$257K
Debt (2021): $257K with participation from PPP
Key Investors in Avilys
PPP
Public-Private Partnership
What's next for Avilys?
With the recent influx of capital, Avilys is poised for significant growth. The large-scale, late-stage funding suggests a strategic focus on scaling operations, potentially expanding its service offerings, and enhancing its technological infrastructure. This investment will likely enable Avilys to broaden its market reach, further solidify its reputation in the sleep disorder treatment sector, and continue its mission of providing accessible, high-quality care for patients suffering from sleep-related ailments.
See full Avilys company page
